Sun Pharmaceutical Industries Board of Directors
Get the latest insights into the leadership at Sun Pharmaceutical Industries. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Dilip S Shanghvi | Chairman & Managing Director |
| Mr. Aalok D Shanghvi | Whole Time Director & COO |
| Ms. Vidhi D Shanghvi | Whole Time Director |
| Mr. Sudhir V Valia | Non Exe.Non Ind.Director |
| Dr. Pawan Goenka | Lead Independent Director |
| Mr. Rama Bijapurkar | Independent Director |
| Mr. Gautam Doshi | Independent Director |
| Mr. Rolf Hoffmann | Independent Director |
Sun Pharmaceutical Industries Share price
SUNPHARMA
1582.3
3.60 (0.23%)NSE
BSE
Last updated on 4 Sep, 2025 | 15:59 IST
BUYSELL
Today's High
1597.00
Today's Low
1561.00
52 Week Low
1553.05
52 Week High
1960.35
The current prices are delayed, login to your account for live prices
LoginSun Pharmaceutical Industries FAQs
The board at Sun Pharmaceutical Industries consists of experienced professionals, including Mr. Dilip S Shanghvi , Mr. Aalok D Shanghvi , and others, overseeing the company’s strategic and corporate governance.
Directors at Sun Pharmaceutical Industries are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Dilip S Shanghvi is the current chairman at Sun Pharmaceutical Industries.
Executive directors at Sun Pharmaceutical Industries are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Sun Pharmaceutical Industries adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Sun Pharmaceutical Industries, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.